(CVGW) Calavo Growers - Ratings and Ratios
Avocados, Guacamole, Tomatoes, Papayas
CVGW EPS (Earnings per Share)
CVGW Revenue
Description: CVGW Calavo Growers October 24, 2025
Calavo Growers, Inc. (NASDAQ: CVGW) is a vertically integrated distributor of fresh avocados, prepared avocado products, and other perishable items, serving grocery, food-service, club, and wholesale channels worldwide. The business is split into two segments-Grown (raw fruit sourcing and distribution) and Prepared (guacamole, avocado pulp, and ready-to-eat items)-and markets its portfolio under a suite of trademarks including Calavo, Avo Fresco, and RIPE NOW!.
Key operational metrics that drive Calavo’s performance include avocado volume (≈ 1.2 million cases / yr in 2023), average selling price (ASP) which tracks Mexican avocado spot prices, and gross margin on prepared products (historically 30-35% vs ≈ 20% on raw fruit). Seasonal supply constraints in Mexico, freight-cost volatility, and U.S. labor-rate inflation are the primary macro-economic levers affecting earnings.
Sector-wide, per-capita avocado consumption in the United States has risen ~ 4% YoY over the past five years, while retail demand for clean-label, ready-to-eat guacamole continues to outpace the broader packaged-foods index, supporting Calavo’s shift toward higher-margin prepared offerings.
For a deeper quantitative breakdown of CVGW’s valuation metrics, the ValueRay platform offers a transparent, data-driven model worth reviewing.
CVGW Stock Overview
| Market Cap in USD | 396m |
| Sub-Industry | Packaged Foods & Meats |
| IPO / Inception | 2002-07-22 |
CVGW Stock Ratings
| Growth Rating | -41.0% |
| Fundamental | 63.3% |
| Dividend Rating | 15.2% |
| Return 12m vs S&P 500 | -32.7% |
| Analyst Rating | 5.0 of 5 |
CVGW Dividends
| Dividend Yield 12m | 3.67% |
| Yield on Cost 5y | 1.23% |
| Annual Growth 5y | -18.80% |
| Payout Consistency | 96.0% |
| Payout Ratio | 59.3% |
CVGW Growth Ratios
| Growth Correlation 3m | -92.8% |
| Growth Correlation 12m | 23% |
| Growth Correlation 5y | -86.8% |
| CAGR 5y | -13.47% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.30 |
| CAGR/Mean DD 3y (Pain Ratio) | -0.52 |
| Sharpe Ratio 12m | -0.83 |
| Alpha | -27.57 |
| Beta | 0.398 |
| Volatility | 36.00% |
| Current Volume | 216.5k |
| Average Volume 20d | 161.5k |
| Stop Loss | 21.1 (-3.2%) |
| Signal | 0.40 |
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (19.9m TTM) > 0 and > 6% of Revenue (6% = 41.6m TTM) |
| FCFTA 0.10 (>2.0%) and ΔFCFTA 5.53pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 12.96% (prev 16.61%; Δ -3.65pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 30.1m > Net Income 19.9m (YES >=105%, WARN >=100%) |
| Net Debt (-60.3m) to EBITDA (30.1m) ratio: -2.00 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.30 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (17.9m) change vs 12m ago 0.32% (target <= -2.0% for YES) |
| Gross Margin 9.85% (prev 9.14%; Δ 0.71pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 202.9% (prev 191.6%; Δ 11.33pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 17.68 (EBITDA TTM 30.1m / Interest Expense TTM 890.0k) >= 6 (WARN >= 3) |
Altman Z'' 3.77
| (A) 0.30 = (Total Current Assets 159.1m - Total Current Liabilities 69.2m) / Total Assets 301.2m |
| (B) 0.09 = Retained Earnings (Balance) 27.6m / Total Assets 301.2m |
| (C) 0.05 = EBIT TTM 15.7m / Avg Total Assets 341.8m |
| (D) 1.15 = Book Value of Equity 27.6m / Total Liabilities 24.0m |
| Total Rating: 3.77 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 63.29
| 1. Piotroski 7.0pt = 2.0 |
| 2. FCF Yield 8.52% = 4.26 |
| 3. FCF Margin 4.13% = 1.03 |
| 4. Debt/Equity 0.02 = 2.50 |
| 5. Debt/Ebitda -2.00 = 2.50 |
| 6. ROIC - WACC (= 2.28)% = 2.84 |
| 7. RoE 9.76% = 0.81 |
| 8. Rev. Trend -62.56% = -4.69 |
| 9. EPS Trend 40.68% = 2.03 |
What is the price of CVGW shares?
Over the past week, the price has changed by -2.42%, over one month by -13.26%, over three months by -17.63% and over the past year by -22.78%.
Is Calavo Growers a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CVGW is around 18.27 USD . This means that CVGW is currently overvalued and has a potential downside of -16.15%.
Is CVGW a buy, sell or hold?
- Strong Buy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CVGW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 35 | 60.6% |
| Analysts Target Price | 35 | 60.6% |
| ValueRay Target Price | 20.2 | -7.4% |
CVGW Fundamental Data Overview November 05, 2025
P/E Trailing = 29.5867
P/E Forward = 18.3486
P/S = 0.5711
P/B = 2.2461
P/EG = 1.66
Beta = 0.398
Revenue TTM = 693.7m USD
EBIT TTM = 15.7m USD
EBITDA TTM = 30.1m USD
Long Term Debt = 24.2m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 3.48m USD (from shortTermDebt, last quarter)
Debt = 3.48m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -60.3m USD (from netDebt column, last quarter)
Enterprise Value = 335.9m USD (396.2m + Debt 3.48m - CCE 63.8m)
Interest Coverage Ratio = 17.68 (Ebit TTM 15.7m / Interest Expense TTM 890.0k)
FCF Yield = 8.52% (FCF TTM 28.6m / Enterprise Value 335.9m)
FCF Margin = 4.13% (FCF TTM 28.6m / Revenue TTM 693.7m)
Net Margin = 2.87% (Net Income TTM 19.9m / Revenue TTM 693.7m)
Gross Margin = 9.85% ((Revenue TTM 693.7m - Cost of Revenue TTM 625.4m) / Revenue TTM)
Gross Margin QoQ = 10.18% (prev 9.49%)
Tobins Q-Ratio = 1.11 (Enterprise Value 335.9m / Total Assets 301.2m)
Interest Expense / Debt = 5.72% (Interest Expense 199.0k / Debt 3.48m)
Taxrate = -26.02% (negative due to tax credits) (-1.81m / 6.95m)
NOPAT = 19.8m (EBIT 15.7m * (1 - -26.02%)) [negative tax rate / tax credits]
Current Ratio = 2.30 (Total Current Assets 159.1m / Total Current Liabilities 69.2m)
Debt / Equity = 0.02 (Debt 3.48m / totalStockholderEquity, last quarter 206.4m)
Debt / EBITDA = -2.00 (Net Debt -60.3m / EBITDA 30.1m)
Debt / FCF = -2.11 (Net Debt -60.3m / FCF TTM 28.6m)
Total Stockholder Equity = 203.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.60% (Net Income 19.9m / Total Assets 301.2m)
RoE = 9.76% (Net Income TTM 19.9m / Total Stockholder Equity 203.7m)
RoCE = 6.91% (EBIT 15.7m / Capital Employed (Equity 203.7m + L.T.Debt 24.2m))
RoIC = 9.75% (NOPAT 19.8m / Invested Capital 203.3m)
WACC = 7.48% (E(396.2m)/V(399.6m) * Re(7.48%) + D(3.48m)/V(399.6m) * Rd(5.72%) * (1-Tc(-0.26)))
Discount Rate = 7.48% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 0.37%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈23.3m ; Y1≈15.3m ; Y5≈6.98m
Fair Price DCF = 7.69 (DCF Value 137.3m / Shares Outstanding 17.9m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 40.68 | EPS CAGR: 9.48% | SUE: -1.87 | # QB: 0
Revenue Correlation: -62.56 | Revenue CAGR: -10.63% | SUE: -1.09 | # QB: 0
Additional Sources for CVGW Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle